Search
Search Results
##search.searchResults.foundPlural##
-
TREATMENT OF ACUTE MYELOID LEUKEMIA WITH 20-30% BONE MARROW BLASTS
3045PDF: 1081HTML: 5664 -
IMMUNOLOGY OF TUBERCULOSIS
5874PDF: 2273HTML: 7369Untitled: 243 -
IMPORTANCE OF CLASSICAL MORPHOLOGY IN THE DIAGNOSIS OF MYELODYSPLASTIC SYNDROME
3597PDF: 2343HTML: 23576Untitled: 273Untitled: 266Untitled: 284 -
Massive pulmonary embolism at the onset of acute promyelocytic leukemia
3622PDF: 952HTML: 1701figure 1: 203Untitled: 229 -
Should every patient with MDS get iron chelation – probably yes.
2419PDF: 1007HTML: 400 -
MYELODYSPLASTIC SYNDROMES AND IRON CHELATION THERAPY
3856PDF: 1364HTML: 2174Fig.1: 261Fig. 2: 252 -
CMV MANAGEMENT WITH SPECIFIC IMMUNOGLOBULINS: A MULTICENTRIC RETROSPECTIVE ANALYSIS ON 92 ALLOTRANSPLANTED PATIENTS. Anti-CMV immunoglobulins for CMV treatment
2743PDF: 1246HTML: 287 -
TREATMENT OF ADVANCED SYSTEMIC MASTOCYTOSIS WITH MIDOSTAURIN: PRACTICAL GUIDANCE FOR OPTIMAL THERAPY AND MANAGEMENT Advanced systemic mastocytosis and midostaurin
1405PDF: 1114HTML: 446 -
Guest Editor: Raffaella Origa IRON TOXICITY AND HEMOPOIETIC CELL TRANSPLANTATION: TIME TO CHANGE THE PARADIGM. IRON TOXICITY AND HEMOPOIETIC CELL TRANSPLANTATION
2079PDF: 1266HTML: 325 -
ALLOGENEIC TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC LEUKEMIA
1509PDF: 863HTML: 1038 -
Cytomorphology of Chimeric Antigen Receptor T-Cells (CAR-T)
1845PDF: 609HTML: 371 -
HEMATOPOIETIC STEM CELL TRNSPLANTATION IN THALASSEMIA AND RELATED DISORDERS
1971PDF: 526HTML: 4052 -
FLT3 Mutated Acute Myeloid Leukemia after CD19 CAR-T Cells
1100PDF: 1295HTML: 136 -
Coagulopathy in Patients with Low/Intermediate Risk Acute Promyelocytic Leukemia treated with First Line Arsenic Trioxide in Combination with All Trans Retinoic Acid: A Monocentric Experience. Coagulopathy in APL treated with ATRA and Arsenic Trioxide.
1244PDF: 1168HTML: 507
1 - 28 of 28 items







